Filing Details
- Accession Number:
- 0001104659-19-063335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 16:18:52
- Reporting Period:
- 2019-11-12
- Accepted Time:
- 2019-11-13 16:18:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Eyegate Pharmaceuticals Inc | EYEG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1619731 | Morton Goldberg | C/O Eyegate Pharmaceuticals, Inc. 271 Waverley Oaks Road, Suite 108 Waltham MA 02452 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-12 | 2,001 | $4.29 | 1,961 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split.
Billionaire Hedge Funds
